Science Explorer Back to mapMap
Discussion
Researcher · University of Southern California · United States

Yan Ning

Yan Ning publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer and Lung Cancer Treatments and Mutations.

OpenAlex
World rank
#3,212,706
of 7,710,434 ranked researchers
Rank in United States
#912,334
of 1,627,098
Works
142
Citations
1.4k
Citations per work
9.7
h-index
19
i10-index 29Top 36% in Molecular Biology
Yan Ning

What does Yan Ning research?

Yan Ning's work is mostly in Medicine (28%), Biochemistry, Genetics and Molecular Biology (17%).

Everything else: 77 works · 54.4% of their workHealth Sciences: 40 works · 28.2% of their workMedicine: 40 works · 28.2% of their workPulmonary and Respiratory Medicine: 15 works · 10.8% of their workOncology: 13 works · 9.1% of their workPathology and Forensic Medicine: 7 works · 5.0% of their workEpidemiology: 5 works · 3.3% of their workLife Sciences: 25 works · 17.4% of their workBiochemistry, Genetics and Molecular Biology: 25 works · 17.4% of their workMolecular Biology: 17 works · 12.2% of their workCancer Research: 7 works · 5.2% of their workTHEIR WORKYan Ning142works
Life Sciences17%Health Sciences28%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else7754.4%
    1. Medicine4028.2%
    1. Biochemistry, Genetics and Molecular Biology2517.4%
  1. 1Molecular Biology12% of their works
  2. 2Pulmonary and Respiratory Medicine11% of their works
  3. 3Oncology9% of their works
  4. 4Cancer Research5% of their works
  5. 5Pathology and Forensic Medicine5% of their works
  6. 6Epidemiology3% of their works

Research topics

Which keywords describe Yan Ning's research?

The keywords of their largest research topics: Chemotherapy, Molecular Characterization, Targeted Therapy, Cetuximab, KRAS Mutations, ALK Inhibitors, EGFR Mutations and Hereditary Syndromes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Chemotherapy282 topics
  2. Molecular Characterization242 topics
  3. Targeted Therapy222 topics
  4. Cetuximab171 topic
  5. KRAS Mutations171 topic
  6. ALK Inhibitors131 topic
  7. EGFR Mutations131 topic
  8. Hereditary Syndromes131 topic
  9. Microsatellite Instability131 topic
  10. Endoscopic Resection111 topic
  11. Gastric Cancer111 topic
  12. Cancer Genomics91 topic
  13. Cluster Algebras91 topic
  14. Deformations91 topic
  15. Hom-Lie Algebras91 topic
  16. Mutational Signatures91 topic
  17. Triangulated Categories91 topic
  18. VEGF51 topic
  19. endothelial progenitor cells51 topic

Where does Yan Ning work?

Yan Ning's main affiliation in the publication record is University of Southern California, United States.

How many publications and citations does Yan Ning have?

OpenAlex counts 142 works and 1,382 citations for Yan Ning, an h-index of 19, ranking #3,212,706 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Yan Ning

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yan Ning. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.